AGREEMENT AND PLAN OF MERGER AND REORGANIZATIONMerger Agreement • August 16th, 2013 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research
This AGREEMENT AND PLAN OF MERGER AND REORGANIZATION, dated as of August 9, 2013 (the “Agreement”), by and between Commonwealth Biotechnologies, Inc., a Virginia corporation (the “Corporation”), and HedgePath Pharmaceuticals, Inc., a Delaware corporation and a wholly-owned subsidiary of the Corporation (the “Subsidiary”).
CONTRIBUTION AGREEMENTContribution Agreement • August 16th, 2013 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Florida
This CONTRIBUTION AGREEMENT (the “Agreement”) is entered into as of August 13, 2013 (the “Effective Date”), by and between Hedgepath, LLC, a Florida limited liability company (formerly known as Hedgepath Pharmaceuticals, Inc., a Florida corporation, “Hedgepath”), and HedgePath Pharmaceuticals, Inc., a Delaware corporation (as successor to Commonwealth Biotechnologies, Inc., a Virginia corporation, the “Company,” and together with Hedgepath, each, a “Party” and collectively, the “Parties”).
